Fitzgerald Meghan Insider Trading Activity

Average Profitability
113.65%
Insider Buys Quantity
1
Insider Buys Sum
$160,224.12
Insider Sells Quantity
3
Insider Sells Sum
$3.76M

Insider Activity of Fitzgerald Meghan

According to the SEC Form 4 filings, Fitzgerald Meghan, being in a position of

  1. director at Roivant Sciences Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 105112 shares for $3.27M,
    over all time since 2026-03-26, has bought 0 shares, and sold 105112 shares for $3.27M.

Biography of Fitzgerald Meghan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,271,6524100

Comparison of Insiders on Amount of Buys and Sells

2026-09-15SaleRoivant Sciences Ltd.
ROIV
director
5,112
0.0007%
$39.74$203,152-8.73%
2026-09-08SaleRoivant Sciences Ltd.
ROIV
director
20,000
0.0027%
$39.90$798,000-12.02%
2026-06-30SaleRoivant Sciences Ltd.
ROIV
director
10,000
0.0014%
$34.90$349,000+1.13%
2026-03-26SaleRoivant Sciences Ltd.
ROIV
director
70,000
0.0098%
$27.45$1.92M+26.18%
2024-08-06SaleTenet Healthcare Corporation
THC
director
20,000
0.0209%
$146.34$2.93M+4.37%
2021-09-16SaleTenet Healthcare Corporation
THC
director
6,077
0.0056%
$72.70$441,798-0.87%
2021-05-24SaleTenet Healthcare Corporation
THC
director
6,153
0.0058%
$63.57$391,146+15.64%
2020-03-17PurchaseTenet Healthcare Corporation
THC
director
12,306
0.0117%
$13.02$160,224+113.65%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.